<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Gibbons | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/causeaction95/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/causeaction95/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Gibbons.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">15e0014eef6f6bd41c184c72a179a040</guid>
				<title>Gibbons posted an update: In this study, Ocimum basilicum (a proven broad spectrum [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38130/</link>
				<pubDate>Tue, 04 Feb 2025 09:39:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>In this study, Ocimum basilicum (a proven broad spectrum medicinal plant for broad-spectrum pharmacological activities) leaf extract was used as conjugates for the fabrication of silver nanoparticles (AgNP). Color change of the reaction mixture and UV-Visible spectrophotometry indicated the fabrication of silver nanoparticles, further X-ray&hellip;<span class="activity-read-more" id="activity-read-more-38130"><a href="http://www.nationalboardinstitute.com/activity/p/38130/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cf862d4542f79516423e187912e9bf21</guid>
				<title>Gibbons posted an update: We propose to exploit such properties for biosensing and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35534/</link>
				<pubDate>Sat, 01 Feb 2025 09:55:03 -0800</pubDate>

									<content:encoded><![CDATA[<p>We propose to exploit such properties for biosensing and neural interfaces.Although previous studies have shown that the host immune response is crucial in determining clinical outcomes in COVID-19 patients, the association between host immune signatures and COVID-19 patient outcomes remains unclear. Based on the enrichment levels of 11 immune&hellip;<span class="activity-read-more" id="activity-read-more-35534"><a href="http://www.nationalboardinstitute.com/activity/p/35534/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e737c8cf3d53b8a542c0b987a842b74a</guid>
				<title>Gibbons posted an update: Cardiovascular diseases (CVD), including pre-eclampsia (PE), [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29695/</link>
				<pubDate>Tue, 28 Jan 2025 13:54:49 -0800</pubDate>

									<content:encoded><![CDATA[<p>Cardiovascular diseases (CVD), including pre-eclampsia (PE), remain the major cause of death and morbidity in women. This review elucidates the current knowledge, state of research and scientific information available on the post-event implications and complications of PE regarding maternal and foetal cardiovascular health. Does PE expose,&hellip;<span class="activity-read-more" id="activity-read-more-29695"><a href="http://www.nationalboardinstitute.com/activity/p/29695/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4546d584e321267e99273f835eee81a9</guid>
				<title>Gibbons became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29672/</link>
				<pubDate>Tue, 28 Jan 2025 13:51:42 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>